How Can Firms Avoid Falling Into GSK-Teva ‘Skinny Label’ Trap?

Industry Must Tread Carefully, Suggests Troy Groetken Of McAndrews, Held & Malloy

 
• By Dave Wallace
  
Man walking into hole
Firms must take care to avoid the pitfalls of the GSK-Teva decision • Source: Alamy

More from Legal & IP

More from Generics Bulletin